Read How Analysts Reacted To Hexcel's Q4 Results

UBS analyst Myles Walton upgraded Hexcel Corp HXL to Neutral from Sell with an unchanged price target of $52, implying an upside of 7%.
The analyst notes the company's Q4 results were mixed as the operating performance was a bit below his expectations, but it still came in better than a much more conservative consensus.
Hexcel shares now appear to be pricing in a balance of risks, Walton adds.
Morgan Stanley analyst Kristine Liwag raised the price target to $57 (an upside of 17%) from $55 and maintained an Underweight rating on the shares.
Recently, the company reported fourth-quarter sales growth of 21.8% year-over-year to $360.3 million, marginally beating the consensus of $359.4 million.
Adjusted EPS improved to $0.16 from $(0.18) a year ago, beating the consensus of $0.13.
Adjusted operating income improved to $25.2 million from $(6.1) million a year ago, and the margin recovered to 7% from -2.1%.
The gross margin for the quarter was 19.2% compared to 10.3% a year ago.
Segment sales: Commercial Aerospace $199.7 million (+57.6% Y/Y); Space & Defense $105.9 million (-11.5% Y/Y); Industrial of $54.7 million (+10.7%Y/Y)
Net cash generated from operating activities for 2021 was $151.7 million, compared to $264.3 million for 2020.
The company declared a quarterly dividend of $0.10 per share payable on February 18, 2022, to stockholders of record as of February 11, 2022.
FY22 Guidance: Hexcel expects sales of $1.50 billion - $1.63 billion (consensus $1.62 billion), Adjusted EPS of $1.00 - $1.24 (consensus $1.27).
Price Action: HXL shares traded lower by 1.59% at $48.52 on the last check Friday.

Market News and Data brought to you by Benzinga APIs

Comments

Earnings Calendar

Never Miss Important Catalysts

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga